Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-ranging randomized trial of OPC-131461 in congestive heart failure with edema
jRCT2071220069Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of OPC-131461 in heart failure (HF) and edema secondary to heart failure (5 arms), sponsored by Otsuka Pharmaceutical Co., Ltd. Primary endpoint: Change in body weight from baseline to last assessment time point by Day 8. Started Jan 2023; status: completed.
02
Drugs
OPC-131461
03
Conditions
heart failure (HF)edema secondary to heart failure
Beyond the preview
Go deeper on jRCT2071220069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071220069.